• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病中的S-亚硝基化:最新进展

S-Nitrosylation in Cardiovascular Disorders: The State of the Art.

作者信息

Mao Caiyun, Zhao Jieyou, Cheng Nana, Xu Zihang, Ma Haoming, Song Yunjia, Sun Xutao

机构信息

Department of Pharmacology, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Department of Typhoid, School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.

出版信息

Biomolecules. 2025 Jul 24;15(8):1073. doi: 10.3390/biom15081073.

DOI:10.3390/biom15081073
PMID:40867518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12383306/
Abstract

Protein S-nitrosylation is a selective post-translational modification in which a nitrosyl group is covalently attached to the reactive thiol group of cysteine, forming S-nitrosothiol. This modification plays a pivotal role in modulating physiological and pathological cardiovascular processes by altering protein conformation, activity, stability, and other post-translational modifications. It is instrumental in regulating vascular and myocardial systolic and diastolic functions, vascular endothelial cell and cardiomyocyte apoptosis, and cardiac action potential and repolarization. Aberrant S-nitrosylation levels are implicated in the pathogenesis of various cardiovascular diseases, including systemic hypertension, pulmonary arterial hypertension, atherosclerosis, heart failure, myocardial infarction, arrhythmia, and diabetic cardiomyopathy. Insufficient S-nitrosylation leads to impaired vasodilation and increased vascular resistance, while excessive S-nitrosylation contributes to cardiac hypertrophy and myocardial fibrosis, thereby accelerating ventricular remodeling. This paper reviews the S-nitrosylated proteins in the above-mentioned diseases and their impact on these conditions through various signaling pathways, with the aim of providing a theoretical foundation for the development of novel therapeutic strategies or drugs targeting S-nitrosylated proteins.

摘要

蛋白质S-亚硝基化是一种选择性的翻译后修饰,其中亚硝基基团共价连接到半胱氨酸的反应性硫醇基团上,形成S-亚硝基硫醇。这种修饰通过改变蛋白质的构象、活性、稳定性和其他翻译后修饰,在调节生理和病理心血管过程中起关键作用。它有助于调节血管和心肌的收缩和舒张功能、血管内皮细胞和心肌细胞的凋亡以及心脏动作电位和复极化。异常的S-亚硝基化水平与多种心血管疾病的发病机制有关,包括系统性高血压、肺动脉高压、动脉粥样硬化、心力衰竭、心肌梗死、心律失常和糖尿病心肌病。S-亚硝基化不足会导致血管舒张受损和血管阻力增加,而过度的S-亚硝基化会导致心脏肥大和心肌纤维化,从而加速心室重构。本文综述了上述疾病中的S-亚硝基化蛋白质及其通过各种信号通路对这些疾病的影响,旨在为开发针对S-亚硝基化蛋白质的新型治疗策略或药物提供理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/1d6a156c7255/biomolecules-15-01073-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/f158e166cfa4/biomolecules-15-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/1f94a5171d38/biomolecules-15-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/3addb82121e5/biomolecules-15-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/abeb9c683857/biomolecules-15-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/d864a3ce0b9b/biomolecules-15-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/1d6a156c7255/biomolecules-15-01073-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/f158e166cfa4/biomolecules-15-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/1f94a5171d38/biomolecules-15-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/3addb82121e5/biomolecules-15-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/abeb9c683857/biomolecules-15-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/d864a3ce0b9b/biomolecules-15-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bb1/12383306/1d6a156c7255/biomolecules-15-01073-g006.jpg

相似文献

1
S-Nitrosylation in Cardiovascular Disorders: The State of the Art.心血管疾病中的S-亚硝基化:最新进展
Biomolecules. 2025 Jul 24;15(8):1073. doi: 10.3390/biom15081073.
2
Dysregulation of Nitrosylation Dynamics Promotes Nitrosative Stress and Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction.亚硝基化动力学失调促进亚硝化应激,并导致射血分数保留的心脏代谢性心力衰竭。
bioRxiv. 2024 Dec 23:2024.12.20.629549. doi: 10.1101/2024.12.20.629549.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
The Role of Protein S-Nitrosylation in Mitochondrial Quality Control in Central Nervous System Diseases.蛋白质S-亚硝基化在中枢神经系统疾病线粒体质量控制中的作用
Aging Dis. 2024 Mar 25;16(5):2641-2658. doi: 10.14336/AD.2024.0099.
5
Endothelial TRPV4-Cx43 signalling complex regulates vasomotor tone in resistance arteries.内皮细胞瞬时受体电位香草酸亚型4-连接蛋白43信号复合体调节阻力动脉的血管运动张力。
J Physiol. 2025 Feb 21. doi: 10.1113/JP285194.
6
Orally administered sodium nitrite prevents the increased α-1 adrenergic vasoconstriction induced by hypertension and promotes the S-nitrosylation of calcium/calmodulin-dependent protein kinase II.口服亚硝酸钠可预防高血压引起的α-1 肾上腺素能血管收缩增加,并促进钙/钙调蛋白依赖性蛋白激酶 II 的 S-亚硝基化。
Biochem Pharmacol. 2023 Jun;212:115571. doi: 10.1016/j.bcp.2023.115571. Epub 2023 Apr 29.
7
Comparison of the Nitric Oxide Synthase Interactomes and S-Nitroso-Proteomes: Furthering the Case for Enzymatic S-Nitrosylation.比较一氧化氮合酶相互作用组和 S-亚硝酰化蛋白质组:进一步支持酶促 S-亚硝酰化。
Antioxid Redox Signal. 2023 Oct;39(10-12):621-634. doi: 10.1089/ars.2022.0199. Epub 2023 Jun 1.
8
Survivin in cardiovascular diseases and its therapeutic potential.存活素在心血管疾病中的作用及其治疗潜力。
Vascul Pharmacol. 2025 Jun;159:107475. doi: 10.1016/j.vph.2025.107475. Epub 2025 Feb 25.
9
HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease.组蛋白去乙酰化酶及其抑制剂对翻译后修饰的作用:心血管疾病的调控
Cells. 2025 Jul 20;14(14):1116. doi: 10.3390/cells14141116.
10
Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions.异常脂肪酸代谢在引发心血管疾病中的分子机制:关键调控靶点与饮食干预
Food Funct. 2025 Jul 28;16(15):5961-5993. doi: 10.1039/d5fo01237f.

本文引用的文献

1
Tissue engineering with targeted delivery of nanotized S-nitrosyl mutant of NEMO ameliorates myocardial infarction.靶向递送纳米化NEMO S-亚硝基化突变体的组织工程改善心肌梗死。
Nanomedicine (Lond). 2025 May;20(10):1085-1099. doi: 10.1080/17435889.2025.2491989. Epub 2025 Apr 16.
2
Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity.循环非编码RNA作为纤维化和心力衰竭严重程度的指标
Cells. 2025 Apr 7;14(7):553. doi: 10.3390/cells14070553.
3
Mitochondrial dysfunction in AMI: mechanisms and therapeutic perspectives.
急性心肌梗死中的线粒体功能障碍:机制与治疗前景
J Transl Med. 2025 Apr 10;23(1):418. doi: 10.1186/s12967-025-06406-5.
4
Engineered silk fibroin bio-hybrid artificial graft with releasing biological gas for enhanced circulatory stability and surgical performance.具有生物气体释放功能的工程丝素蛋白生物杂交人工移植物,可增强循环稳定性和手术性能。
Int J Biol Macromol. 2025 May;309(Pt 2):142760. doi: 10.1016/j.ijbiomac.2025.142760. Epub 2025 Apr 2.
5
Molecular Insights into Ischemia-Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review.冠状动脉疾病缺血再灌注损伤的分子见解:机制与治疗意义:综述
Antioxidants (Basel). 2025 Feb 13;14(2):213. doi: 10.3390/antiox14020213.
6
Promotion of nitric oxide production: mechanisms, strategies, and possibilities.一氧化氮生成的促进:机制、策略及可能性
Front Physiol. 2025 Jan 23;16:1545044. doi: 10.3389/fphys.2025.1545044. eCollection 2025.
7
NEDD4-Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction.NEDD4介导的GSNOR降解加重心脏肥大和功能障碍。
Circ Res. 2025 Feb 14;136(4):422-438. doi: 10.1161/CIRCRESAHA.124.324872. Epub 2025 Jan 23.
8
Dysregulation of Nitrosylation Dynamics Promotes Nitrosative Stress and Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction.亚硝基化动力学失调促进亚硝化应激,并导致射血分数保留的心脏代谢性心力衰竭。
bioRxiv. 2024 Dec 23:2024.12.20.629549. doi: 10.1101/2024.12.20.629549.
9
Hypoxia Microenvironment Preconditioning Attenuated Myocardial Ischemia-Reperfusion Injury via Stc1-Mediating Cardiomyocyte Self-Protection and Neutrophil Polarization.缺氧微环境预处理通过Stc1介导的心肌细胞自我保护和中性粒细胞极化减轻心肌缺血-再灌注损伤。
Adv Sci (Weinh). 2025 Feb;12(6):e2411880. doi: 10.1002/advs.202411880. Epub 2024 Dec 16.
10
Exploring the role of iNOS in HFpEF-Related myocardial fibrosis: Involvement of PTEN-PI3K/AKT signaling pathway.探讨诱导型一氧化氮合酶(iNOS)在 HFpEF 相关心肌纤维化中的作用:PTEN-PI3K/AKT 信号通路的参与。
Biochem Biophys Res Commun. 2024 Nov 19;734:150589. doi: 10.1016/j.bbrc.2024.150589. Epub 2024 Aug 22.